ISPO

Prognostic Evaluation IV

Angiogenin: an indicator of gynecological cancer progression

V Chopra, TV Dinh, EV Hannigan

Prognostic value of histological classification of breast cancer

JP Garne

An evaluation of serum osteocalcin levels in breast cancer - as a marker of bone metastases

MJ Kerin, DM O'Hanlon, C. O'Boyle, T Boyle, D Monaghan,P Fottrell, D Maher, HF Given

Intratumoral heterogeneity of dna ploidy and regional differences in epidermal growth factor and epidermal growth factor receptor of esophageal carcinoma

S Deguchi, Y Muto, T Kusano, S Tomita, T Toda

DNA content and survival rates of patients with transitional cell carcinoma of the urinary bladder

H Al-Abadi, R Nagel

Tetraploidization is a progression step in neoplasia: evidence by tumor karyotype analysis

MJ Worsham, TE Carey, MS Benninger, RJ Zarbo, S Genman,R Grenman, DL Van Dyke

P53-specific antisense oligonucleotides downregulate p53 expression and growth of pancreatic tumor cells

H Ka1thoff, B Busing, A Fiedler, C Roder,J Luttges, K Bleicher, M Majer, D Henne-Bruns

P53 expression in breast cancer related to prognostic factors

A Dziewulska-Bokiniec, D Ciesielski, A Zoltowska, A Roszkiewicz, A Kopacz, J. Wojtacki

Proliferation in precursors of endometrial cancer - immunohistochemical assessment and impact on treatment

H Mecke, J Luttges, E Lehmann-Willenbroock, P Kunstmann, I Semm, MR Parwaresch

Precancerous lesions in the vicinity of invasive breast cancer -an immunohistochemical study of proliferation activity on whole organ sections

J Luttges, J Meins, F Ivanowski, MR Parwaresch

Flow cytometric analysis of early steps in development of adriamycin resistance in a human gastric cancer cell line

S Tanaka, K Aizawa, K Hatakeyama

Localization of anthracyclines accumulated in sensitive & resistant urothelial tumour cell lines

C Davies, P Duffy, A McRobert, M Loizidou, C Inman, A Cooper